Castle Biosciences Inc (CSTL) — Financial Flexibility Index
Castle Biosciences Inc (CSTL) has a Financial Flexibility Index of 0.39x as of September 2025. Free cash flow of $37.47 Million (operating CF $22.63 Million minus capex $14.83 Million) represents 0% of total liabilities ($95.74 Million). Also explore CSTL year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Castle Biosciences Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Castle Biosciences Inc across 8 annual periods. Check asset allocation strategy of Castle Biosciences Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Castle Biosciences Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Castle Biosciences Inc. For the full company profile including market capitalisation, see Castle Biosciences Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.24x | $93.19 Million | $64.87 Million | $75.40 Million | ▲ +859.6% |
| 2023 | 0.13x | $8.00 Million | $-5.63 Million | $62.07 Million | ▲ +117.2% |
| 2022 | -0.75x | $-36.02 Million | $-41.66 Million | $48.18 Million | ▼ -145.2% |
| 2021 | -0.30x | $-15.50 Million | $-18.98 Million | $50.83 Million | ▼ -149.3% |
| 2020 | 0.62x | $14.62 Million | $9.87 Million | $23.64 Million | ▲ +169.3% |
| 2019 | 0.23x | $7.95 Million | $7.01 Million | $34.63 Million | ▲ +162.0% |
| 2018 | -0.37x | $-12.02 Million | $-12.29 Million | $32.47 Million | ▲ +24.1% |
| 2017 | -0.49x | $-11.74 Million | $-12.23 Million | $24.09 Million | — |